DNLRX
Price
$61.77
Change
-$5.31 (-7.92%)
Updated
Dec 17 closing price
VEXMX
Price
$151.65
Change
-$1.77 (-1.15%)
Updated
Dec 17 closing price
Ad is loading...

DNLRX vs VEXMX

Header iconDNLRX vs VEXMX Comparison
Open Charts DNLRX vs VEXMXBanner chart's image
BNY Mellon Active MidCap I
Price$61.77
Change-$5.31 (-7.92%)
VolumeN/A
CapitalizationN/A
Vanguard Extended Market Index Investor
Price$151.65
Change-$1.77 (-1.15%)
VolumeN/A
CapitalizationN/A
DNLRX vs VEXMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DNLRX vs. VEXMX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLRX is a Hold and VEXMX is a Hold.

FUNDAMENTALS
Fundamentals
VEXMX has more cash in the bank: 120B vs. DNLRX (482M). VEXMX (1.09) and DNLRX (1.06) have matching dividends . DNLRX was incepted earlier than VEXMX: DNLRX (22 years) vs VEXMX (37 years). DNLRX is a more actively managed with annual turnover of: 57.46 vs. VEXMX (11.00). DNLRX has a lower initial minimum investment than VEXMX: DNLRX (1000) vs VEXMX (3000). VEXMX annual gain was more profitable for investors over the last year : 23.62 vs. DNLRX (20.23). VEXMX return over 5 years is better than : 60.79 vs. DNLRX (26.53).
DNLRXVEXMXDNLRX / VEXMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years37 years-
Gain YTD19.31621.76589%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets482M120B0%
Annual Yield % from dividends1.061.0998%
Returns for 1 year20.2323.6286%
Returns for 3 years14.1312.75111%
Returns for 5 years26.5360.7944%
Returns for 10 years23.94136.2418%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCLD3.510.11
+3.08%
CareCloud
RYTM56.801.55
+2.81%
Rhythm Pharmaceuticals
MKL1710.14-14.36
-0.83%
Markel Group
OPRX5.23-0.09
-1.69%
OptimizeRx Corp
QTRX11.11-0.30
-2.63%
Quanterix Corp